Further reductions in bone turnover after transition from alendronate to denosumab in ovariectomized cynomolgus monkeys resulted in maintained or improved cortical and trabecular bone mass and bone strength

✍ Scribed by M.S. Ominsky; S.Y. Smith; J. Jolette; F. Vlasseros; R. Samadfam; P.J. Kostenuik

• Book ID: 116321933
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 65 KB
• Volume: 44
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2009.03.395